DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Morrow GL, Abbott RL. Minocycline-induced scleral, dental, and
dermal pigmentation. Am J Ophthalmol, 1998, 125:396–397.
Musch DC, Gillespie BW, Lichter PR, et al. Visual field progression
in the Collaborative Initial Glaucoma Treatment Study:
The impact of treatment and other baseline factors.
Ophthalmology, 2009, 116:200–207.
Parel JM, Villain F. Silicone oils: Physicochemical properties.
In: Ryan SR, Glaser BM, eds. Retina, Vol. 3: Surgical Retina.
St. Louis, Mosby, 1994, pp. 2131–2149.
Park KH, Cozier F, Ong OC, Caprioli J. Induction of heat shock
protein 72 protects retinal ganglion cells in a rat glaucoma
model. Invest Ophthalmol Vis Sci, 2001, 42:1522–1530.
Patel PJ, Bunce C, Tufail A; the ABC Trial Investigators. A randomised,
double-masked phase III/IV study of the efficacy and
safety of Avastin(R) (bevacizumab) intravitreal injections compared
to standard therapy in subjects with choroidal neovascularisation
secondary to age-related macular degeneration:
Clinical trial design. Trials, 2008, 9:56.
Pediatric Eye Disease Investigator Group. A comparison of
atropine and patching treatments for moderate amblyopia by
patient age, cause of amblyopia, depth of amblyopia, and other
factors. Ophthalmology, 2003, 110:1632–1638.
Pediatric Eye Disease Investigator Group. A randomized trial of
atropine vs. patching for treatment of moderate amblyopia in
children. Arch Ophthalmol, 2002, 120:268–278.
Perry HD, Solomon R, Donnenfeld ED, et al. Evaluation of topical
cyclosporine for the treatment of dry eye disease. Arch
Ophthalmol, 2008, 126:1046–1050.
Pieramici DJ, Goldberg MF, Melia M, et al. A phase III, multicenter,
randomized, placebo-controlled clinical trial of topical
aminocaproic acid (Caprogel) in the management of traumatic
hyphema. Ophthalmology, 2003, 110:2106–2112.
Price J, Farish S, Taylor H, O’Day J. Blepharospasm and hemifacial
spasm. Randomized trial to determine the most appropriate
location for botulinum toxin injections. Ophthalmology,
1997, 104:865–868.
Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion
cell death in experimental glaucoma and after axotomy occurs
by apoptosis. Invest Ophthalmol Vis Sci, 1995, 36:774–786.
Riordan-Eva P, Tabbara KF. Anatomy and embryology of the
eye. In: Vaughan D, Asbury T, Riordan-Eva P, eds. General
Ophthalmology, 13th ed. Stamford, CT, Appleton & Lange,
1992.
Robinson JC. Ocular anatomy and physiology relevant to ocular
drug delivery. In: Mitra AK, ed. Ophthalmic Drug Delivery
Systems. New York, Marcel Dekker, 1993, pp. 29–58.
Roig-Melo EA, Macky TA, Heredia-Elizondo ML, Alfaro DV
III. Progressive outer retinal necrosis syndrome: Successful
treatment with a new combination of antiviral drugs. Eur J
Ophthalmol, 2001, 11:200–202.
Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications
of topical mitomycin-C after pterygium surgery.
Ophthalmology, 1992, 99:1647–1654.
Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multi-center,
randomized studies of the efficacy and safety of cyclosporine
ophthalmic emulsion in moderate to severe dry eye disease. CsA
Phase 3 Study Group. Ophthalmology, 2000, 107:631–639.
Sanborn GE, Anand R, Torti RE, et al. Sustained-release ganciclovir
therapy for treatment of cytomegalovirus retinitis. Use
of an intravitreal device. Arch Ophthalmol, 1992, 110:
188–195.
Santaella RM, Fraunfelder FW. Ocular adverse effects associated
with systemic medications: Recognition and management.
Drugs, 2007, 67:75–93.
Schiedler V, Scott IU, Flynn HW Jr, et al. Culture-proven
endogenous endophthalmitis: Clinical features and visual acuity
outcomes. Am J Ophthalmol, 2004, 137:725–731.
Seki M, Lipton SA. Targeting excitotoxic/free radical signaling
pathways for therapeutic intervention in glaucoma. Prog Brain
Res, 2008, 173:495–510.
Sharir M. Topical carbonic anhydrase inhibitors. In: Zimmerman
TJ, Kooner K, Sharir M, Fechtner RD, eds. Textbook of Ocular
Pharmacology, 3rd ed. Philadelphia, Lippincott-Raven, 1997,
pp. 287–290.
Shima C, Sakaguchi H, Gomi F, et al. Complications in patients
after intravitreal injection of bevacizumab. Acta Ophthalmol,
2008, 86:372–376.
Stone EM, Fingert JH, Alward WLM, et al. Identification of a
gene that causes primary open angle glaucoma. Science, 1997,
275:668–670.
Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate
toxicity in retinal ganglion cells. Vision Res, 1997, 37:3483–3493.
Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL. Intraocular
methotrexate in the treatment of uveitis and uveitic cystoid
macular edema. Ophthalmology, 2009, 116:797–801.
Tehrani R, Ostrowski RA, Hariman R, Jay WM. Ocular toxicity of
hydroxychloroquine. Semin Ophthalmol, 2008, 23:201–209.
Thompson S, Pilley SF. Unequal pupils. A flow chart for sorting
out the anisocorias. Surv Ophthalmol, 1976, 21:45–48.
Trobe JD, Sieving PC, Guire KE, Fendrick AM. The impact
of the optic neuritis treatment trial on the practices of
ophthalmologists and neurologists. Ophthalmology, 1999, 106:
2047–2053.
Tsui JK. Botulinum toxin as a therapeutic agent. Pharmacol
Ther, 1996, 72:13–24.
Volpe NJ. The optic neuritis treatment trial: A definitive answer
and profound impact with unexpected results. Arch
Ophthalmol, 2008, 126:996–999.
Vorwerk CK, Lipton SA, Zurakowski D, et al. Chronic low-dose
glutamate is toxic to retinal ganglion cells: Toxicity blocked by
memantine. Invest Ophthalmol Vis Sci, 1996, 37:1618–1624.
Wax MB, Tezel G, Edward D. Clinical and ocular histopathological
findings in a patient with normal-pressure glaucoma.
Arch Ophthalmol, 1998, 116:993–1001.
Weisz JM, Bressler NM, Bressler SB, Schachat AP. Ketorolac
treatment of pseudophakic cystoid macular edema identified
more than 24 months after cataract extraction. Ophthalmology,
1999, 106:1656–1659.
Whitcup SM. Cytomegalovirus retinitis in the era of highly
active anti-retroviral therapy. JAMA, 2000, 283:653–657.
WHO/UNICEF/IVAGG Task Force. Vitamin A Supplements: A
Guide to Their Use in the Treatment and Prevention of Vitamin
A Deficiency and Xerophthalmia. World Health Organization,
Geneva, 1988.
Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease
Study. A controlled trial of topical corticosteroids for herpes simplex
stromal keratitis. Ophthalmology, 1994, 101:1883–1895.
Wybar KC, Karr Muir M. Baillière’s Concise Medical Textbooks,
Ophthalmology, 3rd ed. New York, Baillière Tindall, 1984.
Yoles E, Schwartz M. Elevation of intraocular glutamate levels
in rats with partial lesion of the optic nerve. Arch Ophthalmol,
1998, 116:906–910.
1801
CHAPTER 64
OCULAR PHARMACOLOGY